5GOULD IM. Antibiotic policies to control hosipital-scquired in- fection[J]. J Antimicrob Chemother, 2008, 61(4): 763-765.
6PAPP-WALLACE KM, ENDIMIANI A, TARACILA MA, et al. Carbapenems: past, present, and future [J]. Antimicrobial Agents and Chemotherapy, 2011, 55(11): 4943-4960.
8BOSWALD M, DOBIG C, KANDLER C, et al. Pharmaeokinefie and clinicalevaluation of serious infections in premature and newborn infants under therapy with imipenem/eilastatin[J]. Infec- tion, 1999, 27: 299-304.
